SCHEMBL3402761

SCHEMBL3402761

CN(C)CCCCCCCC(=O)O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4A O75164 12/20 0.68
▸ KDM4C Q9H3R0 12/20 0.68
▸ KDM5A P29375 1/20 0.68
▸ KDM7A Q6ZMT4 1/20 0.68
▸ PHF8 Q9UPP1 1/20 0.68
▸ KDM2A Q9Y2K7 1/20 0.68
▸ TSHR P16473 4/20 0.60
▸ LMNA P02545 2/20 0.60
▸ NFKB1 P19838 1/20 0.60
▸ PMP22 Q01453 1/20 0.60
▸ ALDH1A1 P00352 2/20 0.55
▸ PPARG P37231 3/20 0.54
▸ PPARD Q03181 3/20 0.54
▸ PPARA Q07869 3/20 0.54
▸ GPR84 Q9NQS5 2/20 0.54
▸ HDAC11 Q96DB2 2/20 0.54
▸ TDP1 Q9NUW8 2/20 0.54
▸ SLC22A6 Q4U2R8 1/20 0.54
▸ SLC22A8 Q8TCC7 1/20 0.54
▸ TLR2 O60603 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13286331 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL8213501 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL28020165 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL5530872 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL5219324 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL6029256 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL1176587 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL219327 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
Water SCHEMBL11318112 0.98 KDM4A (0.66) KDM4AKDM4CKDM5AKDM7APHF8
Bromide SCHEMBL1661208 0.98 KDM4A (0.66) KDM4AKDM4CKDM5AKDM7APHF8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320995-A1 IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES CAPSTAN THERAPEUTICS, INC. (US) 2023-10-12 — — US disclosed
US-8501991-B2 P53 activating compounds UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) 2013-08-06 — — US disclosed
EP-2099445-B1 P53 ACTIVATING BENZOYL UREA AND BENZOYL THIOUREA COMPOUNDS UNIV DUNDEE (GB) 2010-11-17 — — EP disclosed
EP-2099445-A2 P53 ACTIVATING BENZOYL UREA AND BENZOYL THIOUREA COMPOUNDS University Court of The University of Dundee (GB) 2009-09-16 — — EP disclosed
WO-2008029096-A2 P53 ACTIVATING BENZOYL UREA AND BENZOYL THIOUREA COMPOUNDS UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) 2008-03-13 — — WO disclosed
EP-0988299-A1 POLYMERISABLE, OPTICALLY ACTIVE DIOXOLANE DIESTERS Rolic AG (CH) 2000-03-29 — — EP disclosed
EP-0988283-A2 PEROXYACIDS UNILEVER PLC (GB) 2000-03-29 — — EP disclosed
WO-1998056760-A1 PEROXYACIDS UNILEVER PLC (GB) 1998-12-17 — — WO disclosed
WO-1998055473-A1 POLYMERISABLE, OPTICALLY ACTIVE DIOXOLANE DIESTERS ROLIC AG (CH) 1998-12-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320995-A1 IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES PLTP, LNPEP, PLIN3 KDM4A 4057/4885KDM4C 4247/4885KDM5A 4704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback